Precise prediction model and simplified scoring system for sustained combined response to interferon-alpha

Area of Science:

• Hepatology
• Virology
• Biostatistics

Background:

• Hepatitis B virus (HBV) infection is a global health concern.
• Interferon-alpha (IFN-alpha) is a treatment option for chronic hepatitis B.
• Predicting treatment response is crucial for optimizing patient selection.

Purpose of the Study:

• To develop a predictive algorithm for selecting optimal candidates for IFN-alpha therapy.
• To establish a scoring system for predicting sustained response to IFN-alpha treatment.

Main Methods:

• A cohort of 474 HBeAg-positive patients receiving IFN-alpha therapy was analyzed.
• Baseline characteristics including liver inflammation (G), fibrosis score (S), HBV DNA, and genotype were evaluated.
• A predictive model and scoring system were developed and validated on a test set.

Main Results:

• Key predictive factors for sustained response included ALT, AST, HBV DNA, genotype, S, G, age, and gender.
• The predictive model achieved accuracies of 86.4% for sustained CR and 93.0% for PR+NR on the training set.
• The scoring system demonstrated a sensitivity of 78.8% and specificity of 80.6%.

Conclusions:

• The developed algorithm and scoring system can aid clinicians in making individualized treatment decisions for IFN-alpha therapy.
• These tools integrate evidence-based medicine with patient-specific characteristics.
• Optimized patient selection may improve treatment outcomes for chronic hepatitis B.